Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	19.96	108.90	90.78
Graham Fair Price	-33.56	8876.52	13359.50
PEG	2.77	-0.25	0.24
Price/Book	9.41	0.94	0.86
Price/Cash Flow	inf	0.00	14.17
Prices/Earnings	153.13	13.85	5.47
Price/Sales	0.40	2.17	2.16
Price/FCF	inf	0.00	14.17
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-45.71	0.10	0.19
Operating Margin	-43.59	0.07	0.12
ROA	-56.62	< 0.005	< 0.005
ROE	0.04	0.02	-56.78
ROIC	< 0.005	< 0.005	-48.18
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	0.04	-87.34
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.28	-0.38	34.75
EPS QOQ	0.23	-0.56	146.31
FCF QOQ	0.02	-1.00	5869.16
Revenue QOQ	-0.12	0.10	-12.43
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	758.68	674.08	-11.15
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.86	0.86	-0.11
Quick Ratio	1.33	1.44	8.27
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	14182.73	14333.36	1.06
Cash	19130.56	20979.87	9.67
Capex	0.00	0.00	0.00
Free Cash Flow	864.21	0.00	inf
Revenue	5662.31	6236.49	10.14
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.41	1.52	8.32
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	79.58	93.87	17.95
Naive Interpretation	Member

06 - Financial Health · Weak

Rating